← All trials
NCT04630444
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 16, 2017
- Primary completion
- Mar 16, 2019
- Completion date
- Mar 16, 2019
- First posted
- Nov 16, 2020
- Last posted
- Nov 16, 2020
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Mclean HospitalLead sponsor
- Brain & Behavior Research FoundationCollaborator
- Mclean HospitalReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.